1. Home
  2. UNH vs NVS Comparison

UNH vs NVS Comparison

Compare UNH & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UnitedHealth Group

UNH

UnitedHealth Group

HOLD

Current Price

$286.77

Market Cap

264.5B

Sector

Health Care

ML Signal

HOLD

Logo Novartis AG

NVS

Novartis AG

HOLD

Current Price

$154.88

Market Cap

310.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNH
NVS
Founded
1977
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.5B
310.4B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
UNH
NVS
Price
$286.77
$154.88
Analyst Decision
Buy
Hold
Analyst Count
25
4
Target Price
$387.79
$118.00
AVG Volume (30 Days)
6.0M
2.2M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
3.08%
2.00%
EPS Growth
N/A
N/A
EPS
13.23
N/A
Revenue
$447,567,000,000.00
N/A
Revenue This Year
N/A
$2.56
Revenue Next Year
$3.31
$4.91
P/E Ratio
$21.71
$23.13
Revenue Growth
11.81
N/A
52 Week Low
$234.60
$97.72
52 Week High
$606.36
$170.46

Technical Indicators

Market Signals
Indicator
UNH
NVS
Relative Strength Index (RSI) 48.05 42.57
Support Level $269.68 $122.16
Resistance Level $294.66 $158.80
Average True Range (ATR) 7.02 2.47
MACD 1.00 -1.86
Stochastic Oscillator 56.79 8.97

Price Performance

Historical Comparison
UNH
NVS

About UNH UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: